🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

In the latest from the Neurology: Education blog, Dr. Peter V. Sguigna DrSguigna reviews the book, "How to Think Like a Neurologist" by Dr. Ethan Meltzer: bit.ly/3joySNO #NeuroEd #MedEd #NeurologyEd

The 6th most read article of 2023: The Evolution of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease. DrSguigna Ethan Meltzer, MD UTSW Neurology UTSW Neurology Residency Dell Medical School UT Health Austin #MOGAD #Demyelinating practicalneurology.com/articles/2023-…

The positive predictive value of MOG-IgG testing based on 2023 criteria for #MOGAD was 78.3% overall and 90.1% for high titer (higher in children than adults and lower in patients without core clinical features). Study from UT Southwestern Medical Center ▶️ journals.sagepub.com/doi/10.1177/20…

In what might be the biggest development for optic neuritis since the optic neuritis treatment trial, John J. Chen, MD, PhD and colleagues were awarded a PCORI grant to study the role of PLEX in optic neuritis (TIMELY-PLEX). Full Article: bit.ly/4epybur #NANOS2024 #opthalmology

#ECTRIMS2024: Society fellow Dr. Amber Salter (Dallas, TX) - Data from 16,794 MS trial participants shows that comorbid (coexisting) conditions make clinical outcomes worse. Read more: ntlms.org/3TvXxiA Get tips for managing comorbidities: ntlms.org/4e5ZMBt

Data presented at #ECTRIMS2024 suggests that assessing retinal layer thickness may assist in predicting risk of #PIRA for people with #Multiple_Sclerosis. practicalneurology.com/news/retinal-l… ECTRIMS National MS Society CMSC Retina Today

At age 31, Dr. Michael Ibarra is an Assistant Professor and has encountered one of the most complex & deadly medical mysteries in his field. “I’ve found support groups that have helped strengthen my mindset, & now I feel extremely motivated...” bit.ly/3zyNdzw

Do you work with #MS patients & caregivers? Join us at the 2024 Brain Summit on Sat. Nov. 16 to discuss symptom management and the use of disease-modifying therapy in the aging MS population. 📆 Register: bit.ly/3XCL11P

If you like fun and if you like #BBQ, might I suggest the zaniest event in Dallas, @meat_fight? There's a feel-good moment, too: It raises money for people living with MS. Tix still available. dallasnews.com/food/restauran…

Awarded the Excellence in Clinical Research - Associate Dean's CRP of the Year award, Patricia Plumb, a UT Southwestern O'Donnell Brain Institute Sr. Research Nurse, hopes to inspire the next generation of clinician scientists. Her fervor for medicine has helped her become a leader at #UTSW for over 18 years!

Meta-analysis of 17 phase 3 MS DMT trials shows higher comorbidity burden is associated with increased risk of relapse and disability progression. #ECTRIMS2024 ja.ma/3ADaAZ8

#Tolebrutinib has received Breakthrough Therapy Designation from the U.S. FDA for adults with non-relapsing secondary progressive #MultipleSclerosis practicalneurology.com/news/btk-inhib… #SPMS Sanofi @Mssociety CMSC MS Focus: The Multiple Sclerosis Foundation

"#GPT-3.5 may be of value in recognizing #NMOSD. However, the manner in which medical information is conveyed, combined with the potential for inaccuracies may result in unnecessary psychological stress." UT Southwestern Medical Center

Our 5th most read article of 2024: Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease by Drs. Valencia-Sanchez (Cristina Valencia-Sánchez) and Wingerchuk, edited by Dr. Samkoff at UR Medicine and Dr. Giesser at PNI. practicalneurology.com/articles/2024-… #MS #NMOSD #Myelin #MOGAD

Microenhancement as a Biomarker for Cerebral Microbleed in Inflammatory Cerebral Amyloid Angiopathy: Insights From 3D T1 Black-Blood MR Imaging hubs.la/Q0332C5H0

A great cross-departmental collaboration initiated by Ty Shang. It was amazing to work with this team! UTSW Neurology UT Southwestern O'Donnell Brain Institute UTSW Radiology

UT System News of the Day: Biopharma company GenrAb is investing in an antibody that can protect cells from the damage that comes from multiple sclerosis. Called TGM-010, the antibody was discovered by UT Southwestern Medical Center neuroimmunologist Nancy Monson in 2017. dallasnews.com/news/2025/02/2…